Monte Rosa Therapeutics, Inc. (GLUE) Shareholders’ equity 2023–2025
Monte Rosa Therapeutics, Inc. (GLUE) shareholders’ equity at each fiscal year-end, per SEC filings.
$233.1MFY2025 · since FY2023: $179.3M → $233.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $233.1M | +4.5% |
| FY2024 | $222.9M | +24.4% |
| FY2023 | $179.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice